Latest MS Stories
DailyGossip.org publishes a useful review to the Natural Multiple Sclerosis Cure program to help patients find a way to feel better and eliminate symptoms Denver,
MISSISSAUGA, ON, June 25, 2014 /CNW/ - Biogen Idec Canada announces today that TECFIDERA(TM) (dimethyl fumarate) is now available for reimbursement in British Columbia (B.C.) through B.C.
Scientists in the University of Connecticut’s Technology Incubation Program have identified a novel approach to treating multiple sclerosis (MS) using human embryonic stem cells, offering a promising new therapy for more than 2.3 million people suffering from the debilitating disease.
11 Friedman Fellows are presenting their work on some of the most cutting-edge diabetes and food & nutrition research in the country, ranging from the role of vitamin D in diabetes, to diabetes
DailyGossip.org publishes a complex review to a new method of curing multiple sclerosis.
CHERRY HILL, N.J., June 5, 2014 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is pleased to announce that the newly published
A new data standard for multiple sclerosis (MS) has been released by the Clinical Data Interchange Standards Consortium (CDISC), the leading global standards organization for clinical research.
The 2014 LDN at the MEET is being organised by the charity the LDN Research Trust in the UK and Mark’s Dugs in the US.
HAYWARD, Calif., May 28, 2014 /PRNewswire/ -- Questcor Pharmaceuticals, Inc.
ROCKLAND, Mass., May 28, 2014 /PRNewswire/ -- EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that Rebif(®) (interferon beta-1a) data will be presented at the 2014
- totally perplexed and mixed up.
More Images (2 images) »